Navigation Links
Patheon to Present New Updates in Drug Formulation and Bioavailability
Date:3/21/2013

(PRWEB) March 21, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will present at a program titled “New Updates in Drug Formulation and Bioavailability” on April 9, 2013, organized jointly by Medicon Valley Alliance, KemiVärlden Biotech and Patheon.

A presentation “Solubility and Bioavailability Enhancement for Poorly Soluble Drugs” will be given by Anil Kane, Executive Director, Global Formulation Sciences, Patheon Inc. on Tuesday, April 9, 2013 at 1:35 p.m. Central European Time. For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

Patheon representatives will also be available to meet during the program, showcasing several of Patheon’s key service offerings, including SoluPath™ - an innovative and cost-effective service used to identify an optimal drug delivery system for compounds with poor bioavailability. In a recent case study, SoluPath™ improved bioavailability by four times in just three months. Learn more by visiting the company’s website at http://www.patheon.com/Services/UniqueSolutions/SoluPath.aspx.    

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10546692.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon to Present at 2013 DCAT Week
2. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
3. Patheon to Present at Informex USA
4. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
5. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
6. Leading Photonics and Laser Researchers to Present Latest Work at SPIE Optics + Optoelectronics
7. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
8. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
9. De nouvelles données mettent en évidence le fardeau considérable que représente la nycturie
10. Palatin Technologies To Present At The 25th Annual ROTH Conference
11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... and Azusa, CA (PRWEB) , ... December 07, ... ... of distributed wastewater treatment and resource recovery solutions for industrial facilities, today announced ... , will be the first to use Cambrian’s novel water-energy purchase agreement (WEPA). ...
(Date:12/7/2016)... Massachusetts (PRWEB) , ... December 07, 2016 , ... Kara Dwyer Dodge grew up hearing ... Dwyer, a third-generation fisherman in Scituate, Mass., found a sea turtle entangled in the lines ... where the turtle became a minor sensation because no one could remember ever seeing one ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Osteoarthritis ... the Federal Drug Administration (FDA) to consider OA as a serious disease. As ... about the growing population of OA patients, many of whom may experience progressive ...
Breaking Biology Technology:
(Date:11/14/2016)... Fla., Nov. 14, 2016  xG Technology, Inc. ("xG" ... providing critical wireless communications for use in challenging operating ... September 30, 2016. Management will hold a conference call ... 5:00 p.m. Eastern Time (details below). Key ... a $16 million binding agreement to acquire Vislink Communication ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
Breaking Biology News(10 mins):